We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Paper Strip Test Could Replace Current Pancreatic Cancer Tests

By LabMedica International staff writers
Posted on 23 Jul 2012
A new approach to clinical laboratory testing could eliminate the need for tissue biopsies to diagnose different types of cancer.

A 15-year-old high school student developed a diagnostic assay that experts say can be developed into medical laboratory test for the detection of pancreatic cancer. More...
The teen’s prize-winning breakthrough test could change how cancer and other fatal diseases are diagnosed and treated.

The new approach to detecting pancreatic cancer is noninvasive, so it does not require a biopsy specimen. It is also inexpensive and fast. At a cost of about USD 3 per test, the diagnostic assay produces a result in five minutes. The detection device was a USD 50 electric meter from a home ware store. The student observed that this diagnostic test would also work with an ordinary diabetes meter.

The student, Jack Andraka, created a clinical laboratory test that uses filter paper dipped into a solution of carbon nanotubes (CN). It detects the levels of mesothelin in blood or urine. Mesothelin is a protein biomarker for pancreatic cancer

“It’s really crucial to detect [pancreatic, lung, and ovarian cancers] in their early stages where survival rates are at their highest,” Jack Andraka declared. “I focused specifically on pancreatic cancer […] due to its extremely low survival rates.”

The test can be adapted to monitor resistance to antibiotics and to follow the progression of treatment of cancer patients undergoing chemotherapy or radiation.

Related Links:

National Cancer Institute




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Gastrointestinal Panel
Xpert® GI Panel
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.